DXCM DexCom, Inc. - Fundamental Analysis
BULLISH
DXCM Stock | Fundamental Analysis & Investment Insights
NASDAQ
•
Healthcare
•
Medical Devices
Current Price
$58.06
Analyst Target
$84.96
+46.3% Upside
52W High
$93.25
52W Low
$54.11
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
88%
Analysis Accuracy
DexCom, Inc. (DXCM) presents a compelling investment opportunity despite near-term price underperformance, with strong fundamentals and accelerating earnings growth driving a significant valuation disconnect. The stock trades at a forward P/E of 28.6x, below the sector average of 36.6x, while delivering robust 21.6% YoY revenue growth and 109.9% YoY earnings growth—both well above peer medians. Profitability metrics are elite, including a 30.64% ROE and 20.05% operating margin, reflecting pricing power and operational leverage in the continuous glucose monitoring (CGM) market. Although insider selling raises caution, the strong analyst consensus of 'strong_buy' and improving earnings trajectory since 2023 suggest confidence in sustained growth ahead.
Key Strengths
21.6% YoY revenue growth significantly outpaces sector average of 10.51%
Exceptional profitability with 30.64% ROE and 20.05% operating margin
Forward P/E of 28.6x is below healthcare sector average of 36.6x, offering relative value
Strong earnings momentum: 109.9% YoY EPS growth and 110.8% Q/Q earnings growth
Dominant position in high-growth CGM market with expanding global adoption
Key Risks
Insider selling trend: $3.76M in sales over last 6 months with no buys
High current valuation relative to historical norms despite sector discount
Stock down 50.1% over 3 years, indicating structural or sentiment challenges
Limited financial transparency with missing data on cash, debt, and shares outstanding
Competition intensifying from Abbott and Medtronic in core CGM segment
AI Fair Value Estimate
Based on comprehensive analysis
$84.96
+46.3% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare DXCM against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations